Key result
Robotic MV repair in infective endocarditis shows 100% freedom from regurgitation or stenosis at one year.
Why the study?
Does robotic assisted mitral valve repair provide safe and effective outcomes in patients with mitral infective endocarditis?
Observational (n=12)
No
Does robotic assisted mitral valve repair provide safe and effective outcomes in patients with mitral infective endocarditis?
Robotic-assisted mitral valve repair is feasible and yields excellent one-year outcomes in selected patients with mitral infective endocarditis.
May support feasibility in selected cases; leaves open need for prospective validation before wider use.
BACKGROUND: Robotic mitral surgery is the most common robotic cardiac procedures. However, in mitral endocarditis the repair become more challenging especially in minimally approach. We applied robotic surgery in mitral endocarditis repair and reviewed our surgical methods and results. PATIENTS: From January 2012 to December 2013, 12 patients with mitral endocarditis in National Taiwan University Hospital were operated via robotic assisted repair. Age of them was among 21 to 65 years old, mean 43. RESULTS: The vegetation involves anterior leaflet in 3, posterior leaflet in 8 and commissural leaflet in 4. Mean cardiopulmonary bypass time is 124 minutes and cross clamp time is 89 minutes. There was no stroke and no operation death. Mitral valve repair technique including anterior leaflet patch augmentation in 2, direct closure of rupture hole on anterior leaflet in one, plication commissural leaflet in 2, and artificial chordae in 10. There was no mitral regurgitation detected immediately after weaning of cardiopulmonary bypass. All of them got free-from-regurgitation or -stenosis rate was 100% at one-year follow. CONCLUSIONS: Although mitral infective endocarditis is complex and difficult to repair, robotic mitral repair in infective endocarditis is feasible. Even in the complex repair group, the cardiopulmonary bypass time is not prolonged and the result is good.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2014) conducted an observational in Mitral endocarditis (n=12). Robotic-assisted mitral valve repair was evaluated on Free-from-regurgitation or -stenosis rate at one-year follow-up. Robotic-assisted mitral valve repair in patients with infective endocarditis resulted in no operative mortality and a 100% freedom from regurgitation or stenosis at one year.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: